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Evaluation of biomaterials as safe and effective therapies needs
preclinical models to estimate their biologic potential. This paper
investigates biocompatibility by the in vivo assessment of the muscle
tissue reaction after implantation of the hidrothermally produced
calciumhydroxyapatite. Specific attention has to be given to the
synthesis technique which influences the stereology of the material and
the behaviour of the material in living tissues. The synthesized powders
of hydroxyapatite are preferentially carbonated hydroxyapatite of the B
type in the form of agglomerates that accommodate two-modal size
pores of 1.5-10 nm and 50-200 nm. The particles are built from
crystallites of 8-22 nm in size, bind inside of the prime particles sized is
between 10 and 63 nm. They form agglomerates of 200 nm in size and
these were further clustered building up the biggest agglomerates of 5-
20 m. Biocompatibility assessment revealed that only mild to
moderate inflammatory reaction was seen around the
calciumhydroxyapatite implants. Calciumhydroxyapatite failed to show
any substantional toxicity.
Key words: biocompatibility, carbonated nano-structured
hydroxyapatite, hydrothermal synthesis, tissue implantation
INTRODUCTION
Calcium hydroxyapatite (CHA) is a superior biocompatible material
because it contains Ca2+, P043– and OH– ions; the ions that human’s tissues and
bones have in relatively high percentage (Hench, 1991; Hench, 1998; Le Geros
and Le Geros, 1998). In the form of very fine crystals CHA accounts for approx 58
per cent of bone mass in mammals. Together with the biocompatibility and non-
toxicity it demonstrates excellent osteoconductivity, (Boskey and Posner, 1976;
Zhang and Gonsalves, 1998; Hench, 1998; Katz and Harper, 1986; Hienerauer et
al., 1991; Zambonin and Grano, 1995) and is widely used for bone reparation and
orthopedic replacements, as well as for dental replacements and reparations
(Panda et al., 2003; Jokanovic and Uskokovic, 2005).
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An interesting approach research is related to hydroxyapatite with a higher
chemical and biochemical activity on the interface with living tissues (i.e proteins
of living organisms) enabling in that way a suitable binding to them.
Hydroxyapatite ceramic is also used as a protective coating of dental
implants, in the bulk form as bone replacement of low (type B) or high (type F)
porosity, and in the granular form for filling bone defects (Katz and Harper, 1986;
Hienerauer et al., 1991; Zambonin and Grano, 1995; Panda et al., 2003). The
commonly released ions from the hydroxyapatite ceramic are Ca2+ and PO43–
ions that are normally present in the tissue’s fluid and therefore there is no allergic
reaction of the tissue to the hydroxyapatite ceramic. In addition, the mitigative
characteristic of hydroxyapatite enables proliferation of patron-ageing living - cells
on the hydroxyapatite ceramic/living tissue interface facilitating the creation of
new bones through the process of osteogenesis. Evaluation of biomaterials as
safe and effective therapies needs preclinical models in order to estimate their
biological potential.
In this paper, special attention was payed to the evaluation of
biocompatibility, which was carried out by the in vivo assessment of the muscle
tissue reaction after implantation of calciumhydroxyapatite.
MATERIALS AND METHODS
Powder synthesis and characterization
Shells of chicken eggs calcined at 900 oC, until carbon was removed
completely and CaCO3 dissociated to CaO, and pure (NH4)2HPO4 (Merck p.a.)
were the precursors for CHA synthesis. The solution mixture was prepared
hydrothermally by using the following conditions: pressure 5x105 Pa, temperature
150 oC and time of autoclaving 8h. An X-ray diffraction (XRD) method, (Philips PW
1050), with Cu-K1-2 radiation, was used for phase analysis of CHA and
determination of the crystallite size and lattice parameters. The PERKIN ELMER
983G IR spectrometer, with the KBr pastille was used for additional phase CHA
powder characterization. The analysis was done in the range of 4000 cm–1 to
400 cm–1. A scanning electron microscope (SEM JEOL 5300) has been used to
analyze the morphology, size distribution and the average size of the CHA
particles at the level of theirs largest agglomerates, as well as their constituents –
the smallest agglomerates of hydroxyapatite; 200 nm in size. An energy
dispersive spectrometer (QX 2000 – Oxford Instruments) combined with the SEM
and a multichannel analyzer was used for the estimation of chemical homogeneity
of synthesized CHA. The nitrogen gas absorption BET method (Sorptomatic
1990, Termoquest CE Instruments) was used for the determination of the specific
surface of CHA powders. The samples for absorption measurements, weighted
between 0.20 – 0.22 g, were thoroughly degassed at 150 oC for 3 hours.
Biological evaluation
Biological evaluation of hydrothermally synthesized calciumhydroxyapatite
(sample 7) was performed using the in vivo tissue reactions in an intramuscular
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implantation model on rabbits (ISO 10993-6). The sample preparation was
performed under sterile conditions in an aseptic chamber. Cylindrical specimens
3 mm wide and 20 mm long were used. One part of the sample, with a length of 10
mm was coated with nonirritable sterile plastic and served as a negative control.
The other part was the tested material in an active contact with the tissue (Fig 1a).
Before the implantation procedure all samples were stored in sterile saline
solution for 60 minutes.
The study animals were four, adult (nine months old) rabbits, each weighing
3-4 kg of both sexes. The animals were kept together in a facility for experimental
animals with a controlled environment and were fed a standard laboratory diet.
Approval was obtained from the Ethics committee of the Faculty of Stomatology,
University of Belgrade (Clearance No 509/03). General anesthesia was induced by
intramuscular injection of 2% xylasine (cp-Pharma, S&M) 3 mg/kg and an
intramuscular injection of 5% ketamine-hydrochloride (Ralatek®, Hemofarm,
Vrsac, S&M) 50 mg/kg body weight. Surgery was carried out under aseptic
conditions and in a manner which minimizes trauma at the implant site. The skin of
the implantation area was shaved and disinfected with an iodine solution. A full
thickness flap was raised to expose the thigh muscle and samples were implanted
into the muscle (Fig 1b). The skin flaps were relocated to fully cover the
experimental site and were fixed with Vicryl sutures (Ethicon®, Norderstedt,
Germany). The animals were held in single cages for 4 weeks, until the end of the
experiment. The experimental animals were sacrificed after the evaluation period
of 4 weeks by intravenous injection of a solution of pentobarbital (100 mg/L).
Macroscopic assessment included examination of each implant site to record the
nature and extent of any tissue reaction observed (Fig 1c, d). The muscle tissue
was then prepared with the standard procedure for histological analysis. After
immersion in 10% buffered formalin for 72 hours, specimens were processed into
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Figure 1. Implantation samples in the muscle tissue
wax. Tissue samples were grounded to a thickness of 5-7 µm and stained with
haematoxylin and eosin ready for light microscopy evaluation.
Evaluation was based on the following biological response parameters:
1. Extent of fibrosis and inflammation (0-none;1-mild;2-moderate;3-severe)
2. Degeneration as determined by changes in tissue morphology (0-none;
1-mild; 2-moderate; 3-severe)
3. Number and distribution as a function of distance from the material/tissue
interface of the inflammatory cell types (polymorphonuclear leucocytes,
lymphocytes, plasma cells, eosinophils, macrophages and multinucleated cells)
(0-none; 1-small amount immediately by implant; 2-small number in a wider
diameter; 3-large number immediately and at distance from the implant)
4. Presence of necrosis as determined by nuclear debris and/or capillary
wall breakdown (0-none; 1-degenerative changes on blood vessels;2- localized
necrotic changes with or without changes on blood vessels adjacent to the
implant; 3-abundant (large) necrotic changes)
5. other parameters such as material debris, fatty infiltration, granuloma.
The results report included a comparative evaluation of the biological
responses to tested and control materials and a descriptive narrative of the
biological response.
RESULTS AND DISCUSSION
Phase analysis and microstructure characteristics of CHA powder
The obtained values for lattice parameters of hydrothermally obtained
hydroxyapatite, evaluated by Reitveld’s methods were a = 0.9428 nm, c =
0.6877 nm and average crystallite size diameter was 16.5 nm. Using IR
spectroscopy it is found that this hydroxyapatite belongs to the carbonated B type
hydroxyapatite. The explanation of this statement can be found in Jokanovic et al.,
2006.
Analysis of SEM microphotographs in Fig. 2 shows the typical shape and
size of particles hydrothermally obtained CHA powders. Powders are constituted
from agglomerates which shapes are nearly the same. The size of agglomerate is
between 5 and 20 µm, and they are built up from fine particles 200 nm in size. The
shapes of agglomerates are irregular with oval edges due to the spherical shape
of individual particles. The greatest part of the agglomerates is 10-20 µm in size.
However, agglomerates as big as 40 µm and as small as 5 µm can be found as
well.
Measurments taken for a more precise value for crystallite size obtained by
X-ray diffraction analysis, illustrate that the microstructure of hydro-thermally
synthesized hydroxyapatite has been developed throughout several stages,
originating from their crystallite structure in size of 16.5 nm to the fine sub-
agglomerate particles in size up to 200 nm. Smaller agglomerates, most
frequently, cluster further into agglomerates of 5-20 µm in size. The smallest
particle size confirmed by analysis of specific surface measurements of
precipitated hydroxyapatite powders by BET absorption method is approximately
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30 nm. By comparing values for particle size and crystallite size of hydroxyapatite
it seems that the crystallites are indeed the finest substructure elements in
hydroxyapatite particles. Similarly to the size distribution at various hierarchical
levels, the pore distribution among them was also estimated. It is obviously,
multimodal and follows up not only the size of primary particles – the smallest
ones – but also the size of other particles packed into powder clustered particles.
The pores are distributed from the smallest ones, in the range of 1.5-10 nm, up to
the largest in the range of 50-200 nm. The largest pores correspond to largest
particles, approximately 200 nm in size, clustered most frequently into
agglomerate particles 20 µm big, what can be seen on the SEM
microphotographs of synthesized CHA.
Biological evaluation
Biocompatibility of dental materials is evaluated on the basis of biological
effect assessment by in vitro tests, by animal experimentations and by clinical
studies on humans (Mjor, 1980; Mendes et al., 2001; Markovic et al., 2004).
Cytotoxicity assay, using established laboratory cell lines according to the ISO
methodology, as a first approach in a standard assay for toxicity screening of
dental materials exhibited good biological acceptance (response) for samples of
calciumhydroxyapatite (Gomes et al., 2001). Those results were an introduction
for further biocompatibility research on experimental animals since results
obtained from the cytotoxicity testing are not sufficient to obtain adequate
knowledge on the biocompatibility of a biomaterial (ISO 10993-6). In order to
define the define biological response animal experiments are designed according
to the ISO methodology and principles of good research practice (Watari et al.,
2004).
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Figure 2. Characteristic microstructures of hydrothermally
obtained hydroxyapatite
Tests for local effects after implantation are performed for some of the
components of materials which can be released during the setting phase or the
biodegradation process leading to direct or indirect contact with almost every part
of the organism. Mostly biocompatibility assessment of calciumhydroxyapatite is
performed on bone tissue because it is predominantly used in periodontal,
maxilofacial and orthopaedic surgery (Markovic et al., 2004; de Rocha Baros et
al., 2002, Denissen et al., 1980). Introduction of the use of calciumhydroxyapatite
in dental pulp pathology, on the other side, needs research that will provide a
more similar tissue reaction such as the one which results from muscle tissue
implantation.
The synthetic nature of biomaterials eludes possible unwanted immune
defense responses therefore when compared with the negative control the true
response reaction to the material can be differentiated from the simple physical
presence of the foreign body.
The muscle around the test and the control implants was normal in almost
all animals. The only sign of inflammation, evident after macroscopic examination
of implanted sites around one sample in one animal, was rubor with the absence
of suppuration or other acute signs of inflammation. However, histological
observations at the end of the evaluation period revealed some changes. Analysis
of fibrous changes in most of the CHA samples showed direct correlation of the
size of irritation with the amount and type of tissue reaction, and can be compared
with the control.
Table 1. Distribution of biological response parameters in experimental and control
samples
Animal Site
Biological response parameters
A B C D
CHA NC CHA NC CHA NC CHA NC
I
I 0 1 0 1 1 0 0 0
II 1 1 1 1 1 0 0 1
II
I 1 1 2 0 2 0 1 0
II 0 1 1 0 1 0 0 0
III
I 1 2 1 0 1 0 1 0
II 1 1 0 0 0 0 0 0
IV
I 0 1 0 0 1 0 0 0
II 1 0 1 0 0 0 1 0
Parameters: A-Extent of fibrosis/fibrous capsule and inflammation, B-Degeneration as determined by
changes in tissue morphology, C-Number and distribution of the inflammatory cell types, D-Number
and distribution of the inflammatory cell types, CHA –calciumhydroxyapatite, NC-negative control
CHA samples induced cystic formation encircled by connective tissue
which served as a cyst wall (Figure 3, upper picture). Inflammatory infiltrate inside
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of the wall was described as mild inflammation. Degenerated cells of muscle
tissue with calciphic dystrophy can be seen (Figure 3, lower picture part).
Formation of fibrous capsules with CHA probably resulted from mechanical
irritation and was not an inflammatory reaction caused by the implanted samples.
Further analysis of the cyst wall showed predominantly spindle-shaped cells,
young fibroblasts and fibrocytes proving the aseptic reaction caused by the
implant was without signs of infection and/or allergic reaction.
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Figure 3. Cystic formation inside the muscle tissue in CHA samples (a - cystic formation, v -
connective tissue, m - muscle tissue, c - calcific dystrophy (H&E, 16x))
Figure 4. Cyst wall inside the muscle tissue at CHA site (c - part of cyst wall, m - muscle
tissue, d - muscle cells with calcium dystrophy (H&E; 64 X))
In some CHA samples there were recorded muscle fibers which were next to
the granulation tissue and showed signs of degeneration. Muscle cells with
calcium dystrophy were seen in different phases of development (Figure 4). The
presence of calcium dystrophy inside the muscle tissue can be caused by
mechanical irritation. This is supported by fibrocytes infiltration originating
probably from muscle bundles covering. Atrophic changes in muscle tissue
morphology with CHA samples immediately around the implanted samples were
mild to moderate and can be compared with the negative control (two samples)
(Table 1).
Furthermore, muscle tissue had multinucleated cells with basophilic
cytoplasm, and present granulation was present with signs of hyperplasia or
calcium dystrophy (Figure 5).
Inside the wall of the cystic formation nerve fibers between muscle bundles
were evident on night magnification. Further magnification revealed degenerative
changes of nerve cells as well as hyaline drops in some of them (Figure 5).
Results from this study showed that with CHA there was a mild infiltration of
the white cells strain with a decrease in their number as the distance from the
implant grew. Predominant cell infiltration at CHA samples was of mononuclear
type, mostly with lymphocytes and macrophages but only in a small amount
adjacent to the implant (Table 1). In only one specimen a small number of
inflammatory cell types in a wider diameter was recorded. Chronic inflammation in
the muscle tissue might result from the duration of the implantation period.
Degenerative changes of blood vessels were recorded in CHA samples.
Diapedesis of white blood cells can be seen on some of the samples in the vein
capillaries. The presence of a white thrombus, as evidence of circular
disturbances resulting from the tested material, was noticed (Table 1).
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Figure 5. The wall of cystic formation in CHA sample: upper picture) N - nerve fibers, zc - the
wall of cystic formation (H&E; 50x). Lower picture) N - nerve cells (detail, higher
magnification) (H&E; 250x)
The so obtained results with hydrothermally obtained hydroxyapatite are in
agreement with other studies reporting a good biocompatibility of hydroxyapatite
(Denissen et al., 1980, Jean et al., 1992). Furthermore, when implanted in muscle
tissue this material induced a satisfactory tissue response.
CONCLUSION
The biocompability of hydrothermally obtained calciumhydroxyapatite has
been investigated in this paper.
In the first part of the paper the structural and morphological characteristics
of calciumhydroxyapatite is given. The measurments were made by using XRD
analysis, IR spectroscopy, SEM microscopy and BET surface analysis. The results
of X-ray diffraction analysis and IR spectroscopy shows that this apatite has a
preferential structure of B-type. The investigation done by the SEM microstructure
and the BET surface analysis clarify that all the obtained powders consist of
agglomerated particles 5-20 m big, built up from particles approx 200 nm big,
and these are clusters of much smaller particles of 10-63 nm. These smallest –
primary – particles are built up by crystallites as big as 16.5 nm.
The main part of investigation shows the relation of biocompability to the
structure and morphological characteristics of nanostructured carbonated
calciumhydroxyapatite obtained by using the hydrthermal method of synthesis.
Test for the muscle tissue reaction after the implantation as a direct contact of the
material and a living tissue gives a valuable data about the organism response. In
agreement with our expectations and most of other researches everywhere done,
CHA shows a good biological acceptance, which is expressed through the mild to
moderate inflammatory reaction resulting only from the mechanical irritation.
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BIOKOMPATIBILNOST NANOSTRUKTURNOG KARBONI^NOG KALCIJUM
HIDROKSIAPATITA DOBIJENOG HIDROTERMALNOM METODOM
MARKOVI] D, @IVOJINOVI] VESNA, JOKANOVI] V i KRSTI] V
SADR@AJ
Evaluacija biomaterijala kao bezbednog i efikasnog materijala u terapiji
zahteva preklini~ke modele da bi se ocenio njihov biolo{ki potencijal. U ovom
radu je in vivo ocenjivana biokompatibilnost hidrotermalno sintetizovanog kalci-
jumhidroksiapatita metodom implantacije u mi{i}no tkivo `ivotinja. Posebnu
pa`nju treba obratiti na tehniku sinteze jer ona uti~e na stereologiju materijala i
ima uticaj na pona{anje materijala u `ivom organizmu. Sintetizovani prah hidrok-
siapatita je uglavnom ugljeni~ni B tip hidroksiapatita u formi aglomerata koji
stvaraju dva modela veli~ine pora od 1,5-10 nm i 50-200 nm. ^estice su izgra|ene
od kristalita veli~ine od 8-22 nm, povezani unutar primarne ~estice ~ija je veli~ina
izme|u 10 i 63 nm. Oni formiraju aglomerate od 200 nm veli~ine a oni dalje grade
ve}e aglomerate od 5-20 µm. Ocenjivanjem biokompatibilnosti uo~ena je blaga
do umerena inflamatorna reakcija u mi{i}nom tkivu oko implantiranih uzoraka.
Kalcijum hidroksiapatit nije ispoljio zna~ajniju toksi~nost.
Acta Veterinaria (Beograd), Vol. 56. No. 5-6, 541-551, 2006. 551
Markovic D et al.: Biocompatibility of nanostructured carbonated
calcium hydroxyapatite obtained by hydrothermal method
